Innovation Pharmaceuticals Inc. (IPIX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 USD | 55.63% |
| 2022 | -0.01 USD | 70.72% |
| 2021 | -0.05 USD | -64.41% |
| 2020 | -0.03 USD | 42.04% |
| 2019 | -0.05 USD | 53.73% |
| 2018 | -0.11 USD | 8.33% |
| 2017 | -0.12 USD | -9.09% |
| 2016 | -0.11 USD | 0.0% |
| 2015 | -0.11 USD | -36.48% |
| 2014 | -0.08 USD | -137.76% |
| 2013 | -0.03 USD | 37.57% |
| 2012 | -0.05 USD | 17.48% |
| 2011 | -0.07 USD | -75.94% |
| 2010 | -0.04 USD | -130.86% |
| 2009 | -0.02 USD | -67.01% |
| 2008 | -0.01 USD | -102.08% |
| 2007 | -0.00 USD | -29.73% |
| 2006 | -0.00 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 USD | -30.77% |
| 2023 Q2 | -0.00 USD | 75.0% |
| 2023 Q1 | -0.00 USD | 22.22% |
| 2023 Q3 | -0.00 USD | -114.29% |
| 2023 Q4 | -0.00 USD | 13.33% |
| 2023 FY | - USD | 55.63% |
| 2022 Q1 | -0.00 USD | 30.77% |
| 2022 FY | - USD | 70.72% |
| 2022 Q4 | -0.00 USD | -12.5% |
| 2022 Q3 | -0.00 USD | 21.95% |
| 2022 Q2 | -0.00 USD | 8.89% |
| 2021 Q2 | -0.02 USD | -391.43% |
| 2021 Q3 | -0.01 USD | 41.86% |
| 2021 Q4 | -0.01 USD | 35.0% |
| 2021 FY | - USD | -64.41% |
| 2021 Q1 | -0.00 USD | 43.55% |
| 2020 FY | - USD | 42.04% |
| 2020 Q2 | -0.01 USD | -64.0% |
| 2020 Q1 | -0.01 USD | 15.73% |
| 2020 Q3 | -0.00 USD | 65.85% |
| 2020 Q4 | -0.01 USD | -47.62% |
| 2019 Q1 | -0.01 USD | 62.5% |
| 2019 Q3 | -0.01 USD | 73.39% |
| 2019 Q4 | -0.01 USD | -43.55% |
| 2019 FY | - USD | 53.73% |
| 2019 Q2 | -0.02 USD | -84.92% |
| 2018 Q2 | -0.03 USD | 3.02% |
| 2018 Q4 | -0.03 USD | -100.0% |
| 2018 FY | - USD | 8.33% |
| 2018 Q1 | -0.03 USD | 19.66% |
| 2018 Q3 | -0.02 USD | 47.66% |
| 2017 Q3 | -0.03 USD | -14.55% |
| 2017 FY | - USD | -9.09% |
| 2017 Q4 | -0.04 USD | -34.2% |
| 2017 Q2 | -0.03 USD | -9.84% |
| 2017 Q1 | -0.02 USD | 9.96% |
| 2016 Q2 | -0.03 USD | -28.44% |
| 2016 Q3 | -0.03 USD | -10.36% |
| 2016 Q1 | -0.02 USD | 18.96% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | -0.03 USD | 12.3% |
| 2015 Q1 | -0.04 USD | -18.56% |
| 2015 Q3 | -0.02 USD | -3.33% |
| 2015 Q2 | -0.02 USD | 39.39% |
| 2015 FY | - USD | -36.48% |
| 2015 Q4 | -0.03 USD | -8.47% |
| 2014 Q4 | -0.03 USD | -52.51% |
| 2014 FY | - USD | -137.76% |
| 2014 Q3 | -0.02 USD | -43.14% |
| 2014 Q2 | -0.02 USD | -57.73% |
| 2014 Q1 | -0.01 USD | 23.02% |
| 2013 FY | - USD | 37.57% |
| 2013 Q1 | -0.01 USD | 70.52% |
| 2013 Q2 | -0.01 USD | -56.86% |
| 2013 Q3 | -0.01 USD | -12.5% |
| 2013 Q4 | -0.01 USD | -40.0% |
| 2012 Q4 | -0.02 USD | -408.82% |
| 2012 FY | - USD | 17.48% |
| 2012 Q2 | -0.02 USD | -108.57% |
| 2012 Q1 | -0.01 USD | 27.59% |
| 2012 Q3 | -0.00 USD | 84.47% |
| 2011 FY | - USD | -75.94% |
| 2011 Q3 | -0.03 USD | -75.34% |
| 2011 Q4 | -0.01 USD | 43.36% |
| 2011 Q1 | -0.01 USD | -14.29% |
| 2011 Q2 | -0.01 USD | -30.36% |
| 2010 FY | - USD | -130.86% |
| 2010 Q2 | -0.01 USD | -120.34% |
| 2010 Q4 | -0.01 USD | -12.64% |
| 2010 Q3 | -0.01 USD | 33.08% |
| 2010 Q1 | -0.01 USD | -68.57% |
| 2009 FY | - USD | -67.01% |
| 2009 Q4 | -0.00 USD | 50.7% |
| 2009 Q3 | -0.01 USD | -102.86% |
| 2009 Q2 | -0.00 USD | -66.67% |
| 2009 Q1 | -0.00 USD | 12.5% |
| 2008 Q1 | -0.00 USD | 5.88% |
| 2008 Q2 | -0.00 USD | -200.0% |
| 2008 FY | - USD | -102.08% |
| 2008 Q3 | -0.00 USD | 60.42% |
| 2008 Q4 | -0.00 USD | -26.32% |
| 2007 Q2 | -0.00 USD | -40.0% |
| 2007 Q3 | -0.00 USD | 35.71% |
| 2007 Q1 | -0.00 USD | 0.0% |
| 2007 Q4 | -0.00 USD | -88.89% |
| 2007 FY | - USD | -29.73% |
| 2006 FY | - USD | 0.0% |